MX9701294A - Un medicamento que contiene un derivado de carnitina para el tratamiento de la arterioesclerosis cronica obliteradora. - Google Patents
Un medicamento que contiene un derivado de carnitina para el tratamiento de la arterioesclerosis cronica obliteradora.Info
- Publication number
- MX9701294A MX9701294A MX9701294A MX9701294A MX9701294A MX 9701294 A MX9701294 A MX 9701294A MX 9701294 A MX9701294 A MX 9701294A MX 9701294 A MX9701294 A MX 9701294A MX 9701294 A MX9701294 A MX 9701294A
- Authority
- MX
- Mexico
- Prior art keywords
- carnithine
- derivative
- medicament containing
- chronic obliterating
- obliterating arteriosclerosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Abstract
Se describe el uso de L-carnitina de propionilo y las sales de esta aceptables en farmacología para producir un medicamento para el tratamiento de la arterioesclerosis cronica obliteradora el cual es selectivamente apropiado para el tratamiento de pacientes con una incapacidad severa de claudicacion intermitente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96830093 | 1996-03-04 | ||
EP96830093A EP0793962B1 (en) | 1996-03-04 | 1996-03-04 | Medicament containing a carnitine derivative for treating arteriosclerosis obliterans |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9701294A true MX9701294A (es) | 1997-09-30 |
MXPA97001294A MXPA97001294A (es) | 1998-07-03 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
ZA971808B (en) | 1998-07-31 |
PT793962E (pt) | 2000-05-31 |
DK0793962T3 (da) | 2000-05-22 |
TW349863B (en) | 1999-01-11 |
ATE187329T1 (de) | 1999-12-15 |
GR3032903T3 (en) | 2000-07-31 |
JPH09323927A (ja) | 1997-12-16 |
CA2198833A1 (en) | 1997-09-04 |
ES2141463T3 (es) | 2000-03-16 |
EP0793962A1 (en) | 1997-09-10 |
EP0793962B1 (en) | 1999-12-08 |
US5811457A (en) | 1998-09-22 |
DE69605531T2 (de) | 2000-05-31 |
DE69605531D1 (de) | 2000-01-13 |
CA2198833C (en) | 2003-07-22 |
KR970064602A (ko) | 1997-10-13 |
KR100346883B1 (ko) | 2003-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
EP0513702A3 (en) | Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication | |
GB9907461D0 (en) | Neurite regeneration | |
NO20053106D0 (no) | Oral, analgesisk doseringsform med forlenget frigivelse. | |
HK1030885A1 (en) | The use of isatin and oxindole derivatives in the preparation of a medicament for use in the treatment of mycobacterial disease | |
CA2176298A1 (en) | A single high dose fluoroquinolone treatment | |
AU1117092A (en) | Treatment of lower urinary tract disorders | |
TW349863B (en) | Carnitine derivative-containing medicament for treating chronic arteriosclerosis obliterans | |
HK1005847A1 (en) | Use of acetyl l-carnitine in the therapeutic treatment of coma | |
IL115589A0 (en) | Use of cck-b antagonists in pharmaceutical compositions | |
RS52011B (sr) | Nova primena derivata taksoida | |
HUT60438A (en) | Application of inhaled non-steroid inflammation reducers for potentiation of antireactive, antiasthmatic effect of inhaled henle's loop-diuretics | |
MY110149A (en) | Compounds for the treatment of neurodegenerative disorders | |
AU1656997A (en) | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer | |
AU3600199A (en) | A pharmaceutical composition containing ezrin mutated on tyrosine 353 | |
YU40398A (sh) | Kompozicija nazalnog spreja za davanje sredstva za lečenje odloženog napada emezisa | |
WO1997005864A3 (en) | Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs | |
SE9602262D0 (sv) | New use of derivatives of cystine | |
FR2802101B1 (fr) | Association de cymemazine et d'un neuroleptique atypique | |
NO953003L (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
NO981320L (no) | Oral anvendelse av (+)-O-demetyltramadol som smertemiddel | |
IT1299069B1 (it) | Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps") | |
TR199801887A2 (xx) | Bir Na+/H+ - de�i�tiricisi inhibit�r�. | |
EE200100122A (et) | R-(+)-alfa-(2,3-dimetoksüfenüül)-1-[2-(4-fluorofenüül)etüül]-4-piperidiinmetanooli kasutamine unehäirete raviks |